Timothy P. Clackson
SVP, Chief Scientific Officer, ARIAD Pharmaceuticals.
Companies
- Elevation Oncology, Inc.Board member Jun 24, 2021 to now1
- Theseus Pharmaceuticals, Inc.Board member Oct 6, 2021 to Mar 2, 20232
- Theseus Pharmaceuticals, Inc.Chief executive officer Oct 6, 2021 to Mar 2, 20232
- Theseus Pharmaceuticals, Inc.President Oct 6, 2021 to Mar 2, 20232
- Forma Therapeutics Holdings, Inc.Board member Jun 18, 2020 to Oct 14, 20223
- F-star Therapeutics, Inc.Board member Mar 5, 2018 to Oct 1, 20204
- ARIAD PharmaceuticalsPresident Jun 25, 2010 to Feb 16, 20175
- ARIAD PharmaceuticalsSVP, Chief Scientific Officer Mar 10, 2006 to Oct 27, 20106
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Forma Therapeutics Holdings, Inc.0 shares7Oct 14, 2022
- Theseus Pharmaceuticals, Inc.351,030 shares8Nov 11, 2022
- Elevation Oncology, Inc.0 shares9Jul 23, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 23, 2025U 47,330 shares at $0.36 of Elevation Oncology, Inc.9
- Sep 1, 2023Gift 15,777 shares of Elevation Oncology, Inc.10
- Nov 11, 2022Bought 2,500 shares at $6.80 of Theseus Pharmaceuticals, Inc.8
- Oct 14, 2022U 7,250 shares of Forma Therapeutics Holdings, Inc.7
- Oct 14, 2022U 23,590 shares of Forma Therapeutics Holdings, Inc.7
- Jun 8, 2022Granted 4,500 shares of Forma Therapeutics Holdings, Inc.11
- May 31, 2022Gift 31,553 shares of Elevation Oncology, Inc.12
- Dec 21, 2021Bought 2,600 shares at $9.76 of Theseus Pharmaceuticals, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARARIAD Pharmaceuticals, President
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Sep 5, 2023
- 11SEC EDGARForm 4 filed Jun 9, 2022
- 12SEC EDGARForm 4 filed Jun 22, 2022
- 13SEC EDGARForm 4 filed Dec 22, 2021